• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refining Risk Stratification for Post-RFA HCC Recurrence.

作者信息

Guo Junwei, Huang Dongsheng

机构信息

The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09046-3.

DOI:10.1007/s10620-025-09046-3
PMID:40237907
Abstract
摘要

相似文献

1
Refining Risk Stratification for Post-RFA HCC Recurrence.完善射频消融术后肝癌复发的风险分层
Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09046-3.
2
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.射频消融治疗肝细胞癌的生存和疾病复发的系统评价和荟萃分析。
Br J Surg. 2011 Sep;98(9):1210-24. doi: 10.1002/bjs.7669. Epub 2011 Jul 15.
3
Radiofrequency ablation of liver tumors: a systematic review.肝脏肿瘤的射频消融：一项系统评价
Arch Surg. 2006 Feb;141(2):181-90. doi: 10.1001/archsurg.141.2.181.
4
Anti-PD-1 synergizes with RFA to suppress abscopal tumors and induce durable memory against recurrence in HCC.抗程序性死亡蛋白1（Anti-PD-1）与射频消融（RFA）协同作用，以抑制肝癌中的远隔效应肿瘤并诱导持久的抗复发记忆。
Liver Res. 2025 May 19;9(2):132-143. doi: 10.1016/j.livres.2025.05.003. eCollection 2025 Jun.
5
Comparison of Computed Tomography and Ultrasound-Guided Radiofrequency Ablation for Recurrent Subdiaphragmatic Hepatocellular Carcinoma After Resection.计算机断层扫描与超声引导下射频消融治疗肝切除术后复发性膈下肝细胞癌的比较
J Hepatocell Carcinoma. 2025 Jun 27;12:1231-1240. doi: 10.2147/JHC.S524399. eCollection 2025.
6
Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma.肝细胞癌射频消融联合或不联合经动脉化疗栓塞术后复发的危险因素、模式及长期生存情况
Front Oncol. 2021 May 27;11:638428. doi: 10.3389/fonc.2021.638428. eCollection 2021.
7
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.肝细胞癌射频消融术后肝内远处复发的危险因素
Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08884-5.
8
Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients.及时消除 HCV 病毒血症对于预防 CHC-HCC 患者 RFA 后复发至关重要。
J Formos Med Assoc. 2019 Aug;118(8):1239-1246. doi: 10.1016/j.jfma.2018.11.014. Epub 2018 Dec 21.
9
Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance.经皮射频消融治疗肝门周围肝细胞癌的长期疗效：肿瘤复发或进展、生存及临床意义。
Cancer Imaging. 2022 Jan 4;22(1):2. doi: 10.1186/s40644-021-00442-2.
10
Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.射频消融、微波消融和冷冻消融治疗极早期和早期 HCC 的总生存和局部复发：系统评价和贝叶斯网络荟萃分析。
Eur Radiol. 2021 Jul;31(7):5400-5408. doi: 10.1007/s00330-020-07610-1. Epub 2021 Jan 13.

本文引用的文献

1
CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study.基于CT的瘤内和瘤周放射组学预测高危肝细胞癌病例对肝动脉灌注化疗联合乐伐替尼及PD-1治疗的反应：一项多中心研究
Hepatol Int. 2025 Jul 23. doi: 10.1007/s12072-025-10877-5.
2
Regulatory role of gut microbiota in immunotherapy of hepatocellular carcinoma.肠道微生物群在肝细胞癌免疫治疗中的调节作用
Hepatol Int. 2025 Apr 14. doi: 10.1007/s12072-025-10822-6.
3
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.
肝细胞癌射频消融术后肝内远处复发的危险因素
Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08884-5.
4
HBcrAg is associated with prognosis of hepatitis B virus-related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy.乙肝核心相关抗原（HBcrAg）与接受抗病毒治疗的肝切除术后乙肝病毒相关肝细胞癌患者的预后相关。
Int J Cancer. 2025 Mar 15;156(6):1293-1303. doi: 10.1002/ijc.35224. Epub 2024 Oct 25.
5
Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein.关于豆凝集素反应性甲胎蛋白百分比的新诊断肝细胞癌的多中心前瞻性分析。
J Gastroenterol Hepatol. 2001 Dec;16(12):1378-83. doi: 10.1046/j.1440-1746.2001.02643.x.